These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 38917696)

  • 41. Measuring Duchenne muscular dystrophy impact: development of a proxy-reported measure derived from PROMIS item banks.
    Schwartz CE; Stark RB; Cella D; Borowiec K; Gooch KL; Audhya IF
    Orphanet J Rare Dis; 2021 Nov; 16(1):487. PubMed ID: 34809687
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cognitive and adaptive deficits in young children with Duchenne muscular dystrophy (DMD).
    Cyrulnik SE; Fee RJ; Batchelder A; Kiefel J; Goldstein E; Hinton VJ
    J Int Neuropsychol Soc; 2008 Sep; 14(5):853-61. PubMed ID: 18764980
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Movement imagery ability: development and assessment of a revised version of the vividness of movement imagery questionnaire.
    Roberts R; Callow N; Hardy L; Markland D; Bringer J
    J Sport Exerc Psychol; 2008 Apr; 30(2):200-21. PubMed ID: 18490791
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Development and Pilot Validation of the DuMAND Checklist to Screen for Duchenne Muscular Dystrophy-Associated Neurobehavioral Difficulties (DuMAND).
    Geuens S; Goemans N; Lemiere J; Doorenweerd N; De Waele L
    J Neuromuscul Dis; 2024; 11(4):801-814. PubMed ID: 38728201
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Upper limb functional assessment scale for children with Duchenne muscular dystrophy and Spinal muscular atrophy].
    Escobar RG; Lucero N; Solares C; Espinoza V; Moscoso O; Olguín P; Muñoz KT; Rosas R
    Rev Chil Pediatr; 2017 Feb; 88(1):92-99. PubMed ID: 28288228
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Measuring quality of life in Duchenne muscular dystrophy: a systematic review of the content and structural validity of commonly used instruments.
    Powell PA; Carlton J; Woods HB; Mazzone P
    Health Qual Life Outcomes; 2020 Aug; 18(1):263. PubMed ID: 32746836
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Motor imagery in stroke patients, or plegic patients with spinal cord or peripheral diseases.
    Dettmers C; Benz M; Liepert J; Rockstroh B
    Acta Neurol Scand; 2012 Oct; 126(4):238-47. PubMed ID: 22587653
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Motor imagery training: Kinesthetic imagery strategy and inferior parietal fMRI activation.
    Lebon F; Horn U; Domin M; Lotze M
    Hum Brain Mapp; 2018 Apr; 39(4):1805-1813. PubMed ID: 29322583
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effects of levodopa on vividness of motor imagery in Parkinson disease.
    Peterson DS; Pickett KA; Earhart GM
    J Parkinsons Dis; 2012; 2(2):127-33. PubMed ID: 23939437
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Internal consistency and construct validity of two versions of the Revised Vividness of Visual Imagery Questionnaire.
    Campos A
    Percept Mot Skills; 2011 Oct; 113(2):454-60. PubMed ID: 22185060
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Motor and cognitive assessment of infants and young boys with Duchenne Muscular Dystrophy: results from the Muscular Dystrophy Association DMD Clinical Research Network.
    Connolly AM; Florence JM; Cradock MM; Malkus EC; Schierbecker JR; Siener CA; Wulf CO; Anand P; Golumbek PT; Zaidman CM; Philip Miller J; Lowes LP; Alfano LN; Viollet-Callendret L; Flanigan KM; Mendell JR; McDonald CM; Goude E; Johnson L; Nicorici A; Karachunski PI; Day JW; Dalton JC; Farber JM; Buser KK; Darras BT; Kang PB; Riley SO; Shriber E; Parad R; Bushby K; Eagle M;
    Neuromuscul Disord; 2013 Jul; 23(7):529-39. PubMed ID: 23726376
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The Vividness of Movement Imagery Questionnaire (VMIQ-2) - Translation and Reliability of a Hebrew Version.
    Ziv G; Lidor R; Arnon M; Zeev A
    Isr J Psychiatry; 2017; 54(2):48-52. PubMed ID: 29248906
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Brain Function and Upper Limb Deficit in Stroke With Motor Execution and Imagery: A Cross-Sectional Functional Magnetic Resonance Imaging Study.
    Ma ZZ; Wu JJ; Hua XY; Zheng MX; Xing XX; Ma J; Li SS; Shan CL; Xu JG
    Front Neurosci; 2022; 16():806406. PubMed ID: 35663563
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The 100-meter timed test: Normative data in healthy males and comparative pilot outcome data for use in Duchenne muscular dystrophy clinical trials.
    Alfano LN; Miller NF; Berry KM; Yin H; Rolf KE; Flanigan KM; Mendell JR; Lowes LP
    Neuromuscul Disord; 2017 May; 27(5):452-457. PubMed ID: 28279570
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Convergent validity and sex invariant factor structure of the Movement Imagery Questionnaire-3 - Second version (MIQ-3S): Healthy, young adult reference data.
    Monsma EV; Gregg MJ; Seiler B; Sacko RS; Hall CR
    Musculoskelet Sci Pract; 2022 Jun; 59():102537. PubMed ID: 35219223
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Right Ventricular Function and T1-Mapping in Boys With Duchenne Muscular Dystrophy.
    Dual SA; Maforo NG; McElhinney DB; Prosper A; Wu HH; Maskatia S; Renella P; Halnon N; Ennis DB
    J Magn Reson Imaging; 2021 Nov; 54(5):1503-1513. PubMed ID: 34037289
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cross-cultural adaptation and validation in spanish of the malocclusion impact questionnaire (MIQ).
    Hope B; Zaror C; Sandoval P; Garay M; Streiner DL
    Health Qual Life Outcomes; 2020 May; 18(1):146. PubMed ID: 32429932
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Investigation of surface electromyography amplitude values during stair climbing task in children with Duchenne muscular dystrophy.
    Bora M; Yalçin A; Bulut N; Yilmaz Ö; Karaduman A; Topuz S; Alemdaroğlu-Gürbüz İ
    Neurol Sci; 2022 Apr; 43(4):2791-2801. PubMed ID: 34608577
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Validation of the Slovenian Version of Motor Imagery Questionnaire 3 (MIQ-3): Promising Tool in Modern Comprehensive Rehabilitation Practice.
    Paravlić A; Pišot S; Mitić P
    Zdr Varst; 2018 Dec; 57(4):201-210. PubMed ID: 30294361
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Functional assessment for people unable to walk due to spinal muscular atrophy and Duchenne muscular dystrophy. Translation and validation of the Egen Klassifikation 2 scale for the Spanish population].
    Fagoaga J; Girabent-Farrés M; Bagur-Calafat C; Febrer A; Steffensen BF
    Rev Neurol; 2015 May; 60(10):439-46. PubMed ID: 25952598
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.